Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway
source: pixabay.com

Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway

Updates from the Phase 3 clinical trial called FIGHT-302 were just released at the 2021 European Society for Medical Oncology World Congress on Gastrointestinal Cancer. The trial is comparing two…

Continue Reading Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway
Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists
source: pixabay.com

Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists

A survey of oncologists has found that more education is clearly needed regarding cholangiocarcinoma. Specifically, more education would be beneficial regarding testing and targeting the mutations which cause the condition…

Continue Reading Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists
Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing
source: pixabay.com

Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing

Researchers from Boston University and Boston Medical Center have recently uncovered that base editing is able to correct the gene mutation which causes alpha-1 antitrypsin deficiency (A1AD). This condition impacts…

Continue Reading Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing
Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
source: pixabay.com

Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis

A study conducted by researchers at Nagoya University in Japan and researchers from Yale University in the United States was recently published in the European Respiratory Journal.  This study utilized single-cell…

Continue Reading Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
source: pixabay.com

Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome

As we've learned more about individuals facing long-term symptoms from COVID-19, we have heard more and more about how it mimics other chronic conditions. For instance, those suffering from chronic…

Continue Reading Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
Phase 2 Trial is Enrolling Participants to Assess the True Prevalence of Allergic Reactions to COVID-19 Vaccines
source: pixabay.com

Phase 2 Trial is Enrolling Participants to Assess the True Prevalence of Allergic Reactions to COVID-19 Vaccines

A new study, funded by the NIH and conducted by Vanderbilt University Medical Center (VUMC), is working to assess allergic reactions to COVID-19 vaccines. The trial will include individuals between…

Continue Reading Phase 2 Trial is Enrolling Participants to Assess the True Prevalence of Allergic Reactions to COVID-19 Vaccines
Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination
source: pixabay.com

Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination

Two new reports of Guillain-Barré syndrome (GBS) have been documented in response to the AstraZeneca COVID-19 vaccine. Previously, published papers have documented 4 cases in England and 7 cases in…

Continue Reading Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination

Individuals with Gastroparesis or Crohn’s Disease May Be More Susceptible to Auto-Brewery Syndrome

Auto-Brewery Syndrome Auto-brewery syndrome is also known as gut fermentation syndrome. It occurs when fungi or bacteria within the gut produce ethanol by endogenous fermentation. Several different strains may be…

Continue Reading Individuals with Gastroparesis or Crohn’s Disease May Be More Susceptible to Auto-Brewery Syndrome
Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy
source: pixabay.com

Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy

Aurinia Pharmaceuticals has just announced that Otsuka Pharmaceutical Europe Ltd. (OPEL), their licensing partner, has just filed a Marketing Authorization Application for an investigative therapy for lupus nephritis (LN) called…

Continue Reading Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy
Phase 3 International Trial for Transthyretin Amyloid Cardiomyopathy is Fully Enrolled
source: pixabay.com

Phase 3 International Trial for Transthyretin Amyloid Cardiomyopathy is Fully Enrolled

Researchers have just announced that they have completed enrollment for a new Phase 3 trial for patients with transthyretin-mediated (ATTR) amyloidosis who have heart disease. This trial is examining a…

Continue Reading Phase 3 International Trial for Transthyretin Amyloid Cardiomyopathy is Fully Enrolled

New Campaign Emphasizes How Migraines Can be Connected to Cyclic Vomiting Syndrome and Gastroparesis

Impel NeuroPharma has been working on a campaign focused on migraines. It is called Reroute Migraine Relief, and it was built in coordination with an artist who suffers from migraines…

Continue Reading New Campaign Emphasizes How Migraines Can be Connected to Cyclic Vomiting Syndrome and Gastroparesis
Investigative Therapy for Endogenous Cushing’s Syndrome is Being Evaluated by The FDA
source: pixabay.com

Investigative Therapy for Endogenous Cushing’s Syndrome is Being Evaluated by The FDA

Strongbridge Biopharma has just announced that the FDA has decided to review the New Drug Application for RECORLEV, a therapy for endogenous Cushing's syndrome. The target action date is January…

Continue Reading Investigative Therapy for Endogenous Cushing’s Syndrome is Being Evaluated by The FDA